Increased tenascin C and toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages

  Catalán, Victoria ^a,b   Gómez Ambrosi, Javier ^a,b   Rodríguez, Amaia ^a,b   Ramírez, Beatriz ^a,b   Rotellar, Fernando ^a,b   Valentí, Victor ^a,b   Silva, Camilo ^a,b   Gil, María J ^a,b   Salvador, Javier ^a,b   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; LIPOPOLYSACCHARIDE; MESSENGER RNA; TENASCIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; EPIDIDYMIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX REMODELING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMOVASCULAR FRACTION CELL;

ADIPOCYTES; ADULT; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; OBESITY; TENASCIN; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84867259104     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1670     Document Type: Article

References (51)

1. Rutkowski JM, Davis KE, Scherer PE 2009 Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 276:5738-5746
2. Mariman EC, Wang P 2010 Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 67:1277-1292
3. Krakoff J 2012 The platform for adipose tissue expansion during positive energy balance. J Clin Endocrinol Metab 97:377-379
4. Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catalán V, Rodríguez A, Jésus Gil MJ, Frühbeck G 2006 Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16:262-269
5. Divoux A, Clément K 2011 Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev 12:e494-e503
6. Christiaens V, Lijnen HR 2006 Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 112:254-259 (Pubitemid 46018367)
7. Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, Ravussin E, Bray GA, Smith SR 2009 Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab 94:5155-5162
8. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA 2010 Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab 299:E1016-EE1027
9. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre- Millo M, Poitou C, Basdevant A, Stich V, Viguerie N, Langin D, Bedossa P, Zucker JD, Clement K 2008 Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9:R14
10. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS 2010 Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 184:2655-2662
11. Piccinini AM, Midwood KS 2010 DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010:672395
12. Midwood KS, Hussenet T, Langlois B, Orend G 2011 Advances in tenascin-C biology. Cell Mol Life Sci 68:3175-3199
13. Chiquet-Ehrismann R, Chiquet M 2003 Tenascins: regulation and putative functions during pathological stress. J Pathol 200:488-499 (Pubitemid 36818249)
14. Udalova IA, Ruhmann M, Thomson SJ, Midwood KS 2011 Expression and immune function of tenascin-C. Crit Rev Immunol 31:115-145
15. Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D 2009 Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 23:11-24
16. Poulain-Godefroy O, Le Bacquer O, Plancq P, Lecoeur C, Pattou F, Frühbeck G, Froguel P 2010 Inflammatory role of Toll-like receptors in human and murine adipose tissue. Mediators Inflamm 2010:823486
17. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, Brennan F, Foxwell B 2009 Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15:774-780
18. Lu YC, Yeh WC, Ohashi PS 2008 LPS/TLR4 signal transduction pathway. Cytokine 42:145-151
19. He Z, Zhu Y, Jiang H 2009 Toll-like receptor 4 mediates lipopo-lysaccharide- induced collagen secretion by phosphoinositide3-kinase-Akt pathway in fibroblasts during acute lung injury. J Recept Signal Transduct Res 29:119-125
20. Jones PL, Jones FS 2000 Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19:581-596
21. Cowan KN, Jones PL, Rabinovitch M 2000 Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105: 21-34 (Pubitemid 30036384)
22. Spencer M, Unal R, Zhu B, Rasouli N, McGehee Jr RE, Peterson CA, Kern PA 2011 Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 96:E1990-E1998
23. Sun K, Kusminski CM, Scherer PE 2011 Adipose tissue remodeling and obesity. J Clin Invest 121:2094-2101
24. Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G 2011 Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. J Clin Endocrinol Metab 96:200-209
25. Rodríguez A, Gómez-Ambrosi J, Catalán V, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G 2009 Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) 33:541-552
26. Frühbeck G, Alonso R, Marzo F, Santidrián S 1995 A modified method for the indirect quantitative analysis of phytate in foodstuffs. Anal Biochem 225:206-212
27. Frühbeck G, Gómez-Ambrosi J 2003 Control of body weight: a physiologic and transgenic perspective. Diabetologia 46:143-172 (Pubitemid 36343879)
28. Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G 2007 Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des 13:2169-2175 (Pubitemid 47074048)
29. Midwood KS, Orend G 2009 The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3:287-310
30. Tanaka H, El-Karef A, Kaito M, Kinoshita N, Fujita N, Horiike S, Watanabe S, Yoshida T, Adachi Y 2006 Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C. Liver Int 26:311-318 (Pubitemid 43349321)
31. Celik A 2011 The relationship between tenascin-C levels and the complexity of coronary lesion after myocardial infarction. J Atheroscler Thromb 18:693-697
32. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P 2009 Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 458:1103-1114
33. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P 2012 Stimulation of inflammatory gene expression in human preadipocytes by macrophage-conditioned medium: upregulation of IL-6 production by macrophage-derived IL-1β. Mol Cell Endocrinol 349:239-247
34. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S 2003 Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278:11888-11896 (Pubitemid 36800160)
35. Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G 2009 Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase- 9 activities in humans. J Mol Med 87:803-813
36. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T 2003 Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor β1. Int J Cancer 105:53-60 (Pubitemid 36418485)
37. Tanaka K, Hiraiwa N, Hashimoto H, Yamazaki Y, Kusakabe M 2004 Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int J Cancer 108:31-40 (Pubitemid 37444440)
38. Huber J, Löffler M, Bilban M, Reimers M, Kadl A, Todoric J, Zeyda M, Geyeregger R, Schreiner M, Weichhart T, Leitinger N, Waldhäusl W, Stulnig TM 2007 Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 31:1004-1013 (Pubitemid 46844776)
39. Todoric J, Löffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhäusl W, Stulnig TM 2006 Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49:2109-2119 (Pubitemid 44168479)
40. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE 2009 Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29:1575-1591
41. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R 1988 Tenascin: cDNA cloning and induction by TGF-β. EMBO J 7:2977-2982
42. Eagan MJ, Zuk PA, Zhao KW, Bluth BE, Brinkmann EJ, Wu BM, McAllister DR 22 September 2011 The suitability of human adipose-derived stem cells for the engineering of ligament tissue. J Tissue Eng Regen Med 10.1002/term.474
43. Rüegg CR, Chiquet-Ehrismann R, Alkan SS 1989 Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 86:7437-7441 (Pubitemid 19254471)
44. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE 2000 The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 275:24255-24263 (Pubitemid 30626513)
45. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747 (Pubitemid 46411051)
46. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R 2009 Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 21:504-511
47. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, Imanaka-Yoshida K 2007 Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol 211:86-94 (Pubitemid 46092033)
48. Tillmann T, Kamino K, Dasenbrock C, Germann PG, Kohler M, Morawietz G, Campo E, Cardesa A, Tomatis L, Mohr U 1999 Ito cell tumor: immunohistochemical investigations of a rare lesion in the liver of mice. Toxicol Pathol 27:364-336
49. El-Karef A, Kaito M, Tanaka H, Ikeda K, Nishioka T, Fujita N, Inada H, Adachi Y, Kawada N, Nakajima Y, Imanaka-Yoshida K, Yoshida T 2007 Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. J Hepatol 46:664-673 (Pubitemid 46400142)
50. Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, Pasanisi F, Contaldo F, Scopacasa F, Capone D 2008 Enhanced serum concentrations of transforming growth factor-β1 in simple fatty liver: is it really benign? J Transl Med 6:72
51. Tarantino G, Scopacasa F, Colao A, Capone D, Tarantino M, Grimaldi E, Savastano S 2011 Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J Gastroenterol 17:5280-5288